After many years without noticeable therapeutic progress, a number of new treatment options for acute myeloid leukemia have recently become available that could improve the situation for those affected. Prof. em. Richard Herrmann, MD, speaks in the Acute Myeloid Leukemia module of Swiss Oncology in Motion with Prof. Mario Bargetzi, MD (Kantonsspital Aarau), Rouven Müller, MD (USZ Zurich) and Prof. Georg Stüssi, MD (IOSI, Ticino).
Moderation:
Richard Herrmann, MD, Prof. em. for Oncology, Riehen/Basel
The following videos can be viewed in full screen mode by right clicking and then clicking on “Open frame in a tab”.
Acute myolic leukemia: basics of the disease (part 1)
Prof. Dr. med. Mario Bargetzi, Head of Hematology, Cantonal Hospital Aarau
Treatment options for fit patients (part 2)
Rouven Müller, MD, Senior Physician, FHM Hematology, USZ Zurich
Options for non-intensively treatable patients and new approaches (Part 3).
Prof. Dr. med. Georg Stüssi Chief Physician of Hematology at the Oncology Institute of Italian Switzerland (IOSI)
